Experiment 909594
Compounds isolated
Details
| Property | Value |
|---|---|
| Pharmacology | |
| Administration route | IV INFUSION |
| Organism | Empty organism |
| Citation | ANON:. (1990). TAXOL.. 15(1) |
| Amount utilized | |
| Compound isolated | |
| Disease | 26 PATIENTS WERE TREATED IN A PHASE I TRIAL. PERIPHERAL NEUROPATHY WAS THE DOSE LIMITING TOXICITY. OTHER SIDE EFFECTS INCLUDED NEUTROPENIA. PR OF 13-22 WEEKS SEEN IN 4/12 PATIENTS. RECOMMENDED DOSE FOR PHASE II TRIAL WAS 250.0 MG/SQ.M. |
| Dose amount | VAR |
| Number | 6 |
| Qualitative result | . |
| Animal | HUMAN ADULT |
| Dose expression | DOSE |